Quest Diagnostics Inc. (DGX)

100.75
1.53 1.50
NYSE : Health Services
Prev Close 102.28
Open 102.20
Day Low/High 100.13 / 102.27
52 Wk Low/High 78.95 / 107.97
Volume 2.67M
Avg Volume 939.10K
Exchange NYSE
Shares Outstanding 134.67M
Market Cap 13.83B
EPS 5.40
P/E Ratio 19.90
Div & Yield 2.12 (2.00%)
Trading Rules in the Quest for Profits

Trading Rules in the Quest for Profits

We are going to use options on Quest Diagnostics to walk through my basics for trading and devise a strategy to maximize profits on the position.

Quest Diagnostics CEO Discusses Q3 2010 Results - Earnings Call Transcript

Quest Diagnostics CEO Discusses Q3 2010 Results - Earnings Call Transcript

Tax Benefit Boosts Quest Diagnostics 3Q Profit

Tax Benefit Boosts Quest Diagnostics 3Q Profit

Quest 3rd-qtr profit rises on tax gain; company boosts profit view but pares revenue forecast

J. Crew: Analyst's Upgrades, Downgrades

J. Crew downgraded at Janney from Buy to Neutral. $37 price target. Company is facing increased competition.

DGX-Quest Diagnostics Inc Q2 Earnings Call Transcript

DGX-Quest Diagnostics Inc Q2 Earnings Call Transcript

DGX-Quest Diagnostics Inc Q2 Earnings Call Transcript

11 Famous Health Care Stocks to Sell

11 Famous Health Care Stocks to Sell

The health care industry has seen a big shakeup in the wake of Obama's health care reform bill and not all stocks in this sector are adapting well.

'Mad Money Lightning Round': Buy Netflix

Cramer says Netflix may be hated on Wall Street but consumers love it.

Quest Diagnostics Sees Bullish Move

At least one investors bought calls today expectations of a rise in the stock.

Health Discovery Corporation And Smart Personalized Medicine Form Agreement For Developing Laboratory Tests For Breast Cancer Therapy Selection With Quest Diagnostics

Health Discovery Corporation (OTCBB: HDVY) (HDC) and Smart Personalized Medicine, LLC (SPM) announced today that they have entered into development and related licensing agreements with Quest Diagnostics Incorporated...

Biotech Stock Mailbag: Health Discovery

Biotech Stock Mailbag: Health Discovery

Our senior biotech columnist answers readers' questions about Health Discovery, Discovery Labs and other newsworthy healthcare stocks.

Apple: Analysts' Upgrades, Downgrades

Apple target, estimates raised at Credit Suisse, Barclays and Goldman.

Quest Down; But Is Market Diagnosis Right?

Quest Diagnostics is down on Monday after an in-line earnings report, presenting investors with a decision on whether to buy the health care stock on short-term weakness.

Value Stocks to Consider as Market Drops

Value Stocks to Consider as Market Drops

Lincoln Educational Services, TreeHouse Foods, Quest Diagnostics, General Mills and Church & Dwight are rated 'buy.'

Five Large-Caps to Lead S&P 500

DirecTV, McDonald's, Medco, Quest Diagnostics and General Mills are rated 'buy.'

Top Blue-Chip Stocks Jump 59% in a Year

Top Blue-Chip Stocks Jump 59% in a Year

Medco, Colgate-Palmolive, General Mills and two other companies get the highest recommendations from TheStreet.com Ratings.

ETFs for Health Care Quagmire

ETFs for Health Care Quagmire

The iShares Dow Jones U.S. Healthcare Providers Index ETF and PowerShares Dynamic Healthcare Services ETF allow investors to target the area most threatened by the health care legislation.

White House Jobs Forum Focuses On Job Creation

White House Jobs Forum Focuses On Job Creation

Business and labor leaders, local officials discuss job strategies at White House forum

Obama Convenes Jobs Summit

Obama Convenes Jobs Summit

The White House jobs summit convenes Thursday, with 130 corporate honchos, union leaders and eggheads

Feds Seek Rehearing Of Baseball Drug List Ruling

Feds Seek Rehearing Of Baseball Drug List Ruling

Feds seek rehearing of appeals court ruling that said baseball drug list seizure was illegal

Health Care ETFs See Hope

Health Care ETFs See Hope

Health care ETFs have rebounded a little as the momentum for Obama's health care reforms has slowed.

Quest Diagnostics Will Maintain 2009 Forecasts

Quest Diagnostics Will Maintain 2009 Forecasts

Ahead of Wednesday conference, Quest Diagnostics reiterates 2009 profit and revenue estimates

Kass: The Earnings Season Racket

Kass: The Earnings Season Racket

The beats are from lowered and depressed guidance, and there have been many high-profile forward-quarter guide downs.

Quest Diagnostics Boosts 2009 Profit Outlook

Quest Diagnostics Boosts 2009 Profit Outlook

Quest Diagnostics predicts bigger profit and maintains sales guidance after 3rd-qtr report

Quest 3Q Profit Climbs Due To Lower One-time Costs

Quest 3Q Profit Climbs Due To Lower One-time Costs

Quest Diagnostics says profit rose 73 percent as testing volume held up and charges decreased

Sector Snap: Quest And LabCorp Downgraded

Sector Snap: Quest And LabCorp Downgraded

Credit Suisse analyst cuts Quest and LabCorp to 'Neutral,' lowering targets and 2010 estimates

Men Walk Away From Fiery Small Plane Crash In NJ

Men injured but manage to walk away from fiery small plane crash near NJ's Teterboro Airport

Under the Radar: Healthy Haemonetics

Under the Radar: Healthy Haemonetics

As demand for blood is rising, Haemonetics is offering among the safest products.

Cramer's 'Mad Money' Recap: Banking on Health Care (Final)

Cramer says health care will replace oil as one of the three leaders of the market Click for news from Jim Cramer.

Cramer's 'Stop Trading!': Health Care Stocks

Jim Cramer finds opportunity in three health care stocks.

Cramer's 'Mad Money' Follow-Up: Stock-Market Bargains

Cramer's 'Mad Money' Follow-Up: Stock-Market Bargains

Here's how some of Tuesday's 'Mad Money' stocks fared on Wednesday.

TheStreet Quant Rating: B+ (Buy)